Skip to main content

Glaucoma Australia works with its partners to develop continuing medical education activities for ophthalmologists, optometrists, pharmacists and orthoptists. Please see current opportunities below.

Glaucoma Now

Glaucoma Now is a continuing medical education publication aimed at general ophthalmologists, ophthalmology residents and glaucoma specialists.

Individual issues of Glaucoma Now are accredited for 4 Continuing Medical Education (CME) Credits and e-learning assessments are aligned to each issue.

Australian Vision Convention

Following the conference, all delegates now have access to the AVC 2022 Virtual Platform for 4 months. During this time, you can increase your CPD hours by watching on-demand recordings of plenary and workshop sessions plus a library of pre-recorded content.

You will not be able to access the platform after midnight 10 August 2022.

Disease State Management

Early detection and adherence to treatment are vital to slow glaucoma progression. Pharmacists have a vital role to play in counselling patients to have regular eye checks and, for those with glaucoma, ensuring adherence to their prescribed medications and regular review.
 
This activity has been accredited for 1.5 hours of Group 1 CPD (or 1.5 CPD credits) suitable for inclusion in an individual pharmacist’s CPD plan, which can be converted to 1.5 hours of Group 2 CPD (or 3 CPD credits) upon successful completion of relevant assessment activities.

OCT – Indispensable in the Diagnosis of Glaucoma

Dr Shweta Kaushik discusses optical coherence tomography (OCT) having a widespread utility in eye care. People with glaucoma benefit from the inclusion of OCT in the diagnostic work-up through earlier diagnosis and reliable identification of glaucoma progression.
 
1.5T hours with Assessment - Optometry Australia IoE Quality Assurance, 0.5CD in New Zealand.

Preserflo MicroShunt: A New Approach to POAG

Dr Nathan Kerr discusses procedures that promise to predictably lower IOP while reducing risks and accelerating recovery, thereby enabling patients to have surgery at an earlier stage before significant vision loss has already occurred. An understanding of these new interventions, and where they fit in the treatment paradigm, is important in providing the highest-level of patient care for people with glaucoma.

1.25T hours with Assessment – Optometry Australia IoE Quality Assurance, TBC in New Zealand.

The Psychosocial Impact of Glaucoma

Glaucoma is a common eye condition that optometrists and ophthalmologists need to manage. The initial diagnosis is often unexpected by patients, and the uncertainty of living with a condition that could take away their vision is both worrying and terrifying for them. The diagnosis carries many psychosocial burdens. Dr Jonathan Kam explains that a good clinician-patient relationship can encourage treatment compliance and prevent vision loss.
 
1.25N hours with Assessment - Optometry Australia IoE Quality Assurance, 0.5GE in New Zealand.

It's Glaucoma…Isn't It?

Glaucoma is a diagnosis of exclusion. With this in mind, Henrietta Wang and Dr Jack Phu present several cases of optic neuropathies seen in a glaucoma clinic that are not glaucoma. In doing so, the article reinforces the importance of the differential diagnosis process. Along the way, we provide some clinically relevant tips for clinicians to apply to their practice.

1 hour with Assessment - Optometry Australia IoE Quality Assurance, 0.5CD + 0.5GE in New Zealand.

The Future of Glaucoma Management

Dr Jeremy Tan, Dr Jessica Tang, and Associate Prof. Ashish Agar present some of the most exciting developments from last decade in the management of glaucoma, the leading cause of irreversible blindness worldwide have been introduced. From improvements in medication targeting and delivery, to neuroprotection and advances in surgical techniques, this review outlines treatments on the horizon in our fight against the silent thief of sight.

1.25T hours with Assessment - Optometry Australia IoE Quality Assurance, 1GE in New Zealand.

Fighting Glaucoma: The Treatment Cascade

In this two part article, Dr Katherine Masselos and Dr Samuel Dance present a logical cascade of currently available treatment options for patients living with glaucoma, the world’s leading cause of irreversible blindness. Part one discusses medications – both topical and future implantable options – while part two presents laser and surgical interventions for glaucoma management, and describes when each is most likely to be used.

1.5T hours with Assessment - Optometry Australia IoE Quality Assurance, 0.75GE in New Zealand.